506441-97-0

Upstream product

• 506441-96-9 1,6-di-tert-butyldimethylsilyl 2-deoxy-3-O-hexanoyl-2-(hexanoylamino)-β-D-glucopyranoside 
• 506441-94-7 tert-butyldimethylsilyl 2-deoxy-3-O-hexanoyl-2-(hexanoylamino)-β-D-glucopyranoside 
• 506441-93-6 tert-butyldimethylsilyl 2-deoxy-4,6-O-isopropylidene-2-(hexanoylamino)-β-D-glucopyranoside 
• 13996-79-7 2-Desoxy-2-hexanoylamino-D-glucose 
• 2051-49-2 n-hexanoic anhydride 
• 506441-95-8 1,6-di-tert-butyldimethylsilyl 4-O-(benzyloxycarbonyl)-2-deoxy-3-O-hexanoyl-2-(hexanoylamino)-β-D-glucopyranoside 

Downstream Products

• 506442-03-1 tert-butyldimethylsilyl 4-O-(benzyloxycarbonyl)-6-O-[6-O-(benzyloxycarbonyl)-4-O-[bis(benzyloxy)phosphoryl]-2-deoxy-3-O-hexanoyl-2-(hexanoylamino)-β-D-glucopyranosyl]-2-deoxy-3-O-hexanoyl-2-(hexanoylamino)-β-D-glucopyranoside 
• 506442-02-0 tert-butyldimethylsilyl 4-O-(benzyloxycarbonyl)-6-O-[6-O-(benzyloxycarbonyl)-4-O-[bis(benzyloxy)phosphoryl]-2-deoxy-3-O-hexanoyl-2-[[(2,2,2-trichloroethoxy)carbonyl]amino]-β-D-glucopyranosyl]-2-deoxy-3-O-hexanoyl-2-(hexanoylamino)-β-D-glucopyranoside 

Relevant academic research and scientific papers

Synthesis of lipid A derivatives and their interactions with polymyxin B and polymyxin B nonapeptide

Lipid A is the causative agent of Gram-negative sepsis, a leading cause of mortality among hospitalized patients. Compounds that bind lipid A can limit its detrimental effects. Polymyxin B, a cationic peptide antibiotic, is one of the simplest molecules c